Clinical Trial Update: Female Sex is an Independent Predictor of Death and Bleeding Among Fibrinolytic Treated Patients With AMI [Phase 3]

View source ↗

Summary

In this Phase 3 trial update, female sex is reported as an independent predictor of death and bleeding among patients with acute myocardial infarction treated w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Snippet

Sponsor: NYU Langone Health | Conditions: Myocardial Infarction | Phase 3 | Status: COMPLETED